BioVie Inc. Operating Lease, Liability, Noncurrent
BioVie Inc. (BIVI) had Operating Lease, Liability, Noncurrent of $184.42 thousand as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $184.42K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $213.32K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $232.52K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $254.37K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $184.42K 10-K · filed 2026-08-13 |
| 2026-03-31 | $213.32K S-1/A · filed 2026-08-06 |
| 2025-12-31 | $232.52K 10-Q · filed 2026-02-06 |
| 2025-09-30 | $254.37K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $275.43K 10-K · filed 2026-08-13 |
| 2025-03-31 | $295.72K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $314.92K 10-Q · filed 2025-02-11 |
| 2024-09-30 | $332.73K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $349.89K S-1/A · filed 2026-08-06 |
| 2024-03-31 | $366.43K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $17.60K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $30.22K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $42.51K 10-K · filed 2024-09-30 |
| 2023-03-31 | $54.47K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $65.83K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $76.77K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $87.41K 10-K · filed 2023-08-16 |
| 2022-03-31 | $97.78K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |